Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 88551-88600 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05802875
Building Resilience During the COVID-19 Pandemic: a Randomized Controlled Trial
NARecruiting
192 participants
Started: Apr 1, 2022 · Completed: Jan 31, 2026
3 conditions1 sponsor1 location
NCT03895827
Recovery Initiation and Management After Overdose (RIMO) Experiment
NAActive, not recruiting
251 participants
Started: Apr 1, 2022 · Completed: Mar 31, 2025
1 condition2 sponsors1 location
NCT05289245
A National Registry on Chinese Patients With Cystic Fibrosis
N/ARecruiting
200 participants
Started: Apr 1, 2022 · Completed: Oct 1, 2032
1 condition1 sponsor1 location
NCT06221787
Stem Cell Derived Exosomes in the Treatment of Melasma and Its Percutaneous Penetration
NARecruiting
80 participants
Started: Apr 1, 2022 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT05345418
Umbilical Cord-Derived Mesenchymal Stem Cell (VCELL 1) for Male Patients With Sexual Deficiency
PHASE1/PHASE2Recruiting
158 participants
Started: Apr 1, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05423990
Electroclinical Features of Sudden Unexpected Death in Epilepsy (SUDEP) : a Multi-center Observational Study
N/AEnrolling by invitation
30 participants
Started: Apr 1, 2022 · Completed: Apr 1, 2024
2 conditions1 sponsor1 location
NCT04460521
The ACTS Trial: N-acetylcysteine (NAC) and Night-splinting as a Non-operative Treatment for Carpal Tunnel Syndrome
PHASE4Recruiting
240 participants
Started: Apr 1, 2022 · Completed: Oct 1, 2026
6 conditions1 sponsor1 location
NCT06282679
Clinical Observation of Botulinum Toxin A Treatment in the Treatment of Rosacea
NARecruiting
30 participants
Started: Apr 1, 2022 · Completed: Jun 28, 2024
2 conditions1 sponsor1 location
NCT05218148
SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma
PHASE2Not yet recruiting
44 participants
Started: Apr 1, 2022 · Completed: Dec 1, 2025
7 conditions1 sponsor1 location
NCT05294068
Barriers to Physical Activity in Patients With Cognitive, Neuromotor or Sensory Impairments During Aging
N/ARecruiting
1,000 participants
Started: Apr 1, 2022 · Completed: Feb 1, 2034
1 condition2 sponsors1 location
NCT04068155
Alpha Radiation Emitters Device for the Treatment of of Malignant Cutaneous Tumors
NARecruiting
80 participants
Started: Apr 1, 2022 · Completed: Jan 31, 2025
3 conditions1 sponsor2 locations
NCT05104658
Heart Rehabilitation for All
NAActive, not recruiting
218 participants
Started: Apr 1, 2022 · Completed: Dec 31, 2026
4 conditions4 sponsors1 location
NCT05428735
The DRAGON 2 Trial
NARecruiting
348 participants
Started: Apr 1, 2022 · Completed: Jun 30, 2029
2 conditions1 sponsor24 locations
NCT05237141
Etonogestrel Implant as Emergency Contraception
PHASE4Recruiting
12 participants
Started: Apr 1, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05864664
Safety and Efficacy of Wide Awake Local Anesthesia no Tourniquet Technique (WALANT) in Ankle Removal of Implant Surgery
NARecruiting
40 participants
Started: Apr 1, 2022 · Completed: Nov 1, 2023
3 conditions1 sponsor1 location
NCT04920864
RTMS, Stress and Opioid Use Disorder
NAActive, not recruiting
32 participants
Started: Apr 1, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05253677
Precise Procedural and PCI Plan (P4)
NARecruiting
1,000 participants
Started: Apr 1, 2022 · Completed: Oct 31, 2026
1 condition1 sponsor17 locations
NCT05298150
Remote Dynamic Cycling for the Customized Off-site Rehab in Parkinson's Disease
NARecruiting
72 participants
Started: Apr 1, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05185778
Parasitism & COVID19 Vaccines: New Challenge.
N/ANot yet recruiting
128 participants
Started: Apr 1, 2022 · Completed: Oct 30, 2025
2 conditions1 sponsor0 locations
NCT05203120
A National Phase II Study of Proton Therapy in Hepatocellular Carcinoma
NARecruiting
50 participants
Started: Apr 1, 2022 · Completed: Jan 1, 2030
1 condition6 sponsors3 locations
NCT05236413
The Effect of a High Fiber Diet and High-Intensity Interval Exercise in Patients With HFpEF
NARecruiting
36 participants
Started: Apr 1, 2022 · Completed: Aug 1, 2025
1 condition2 sponsors1 location
NCT06487611
The Presence of Humanoid Robot With Older Adults at Homes
NAActive, not recruiting
60 participants
Started: Apr 1, 2022 · Completed: Sep 27, 2024
5 conditions1 sponsor1 location
NCT05577598
Glucose Consumption During Deep Brain Stimulation With Functional [18F]FDG-Brain-PET in Obsessive-Compulsive Disorder
NARecruiting
8 participants
Started: Apr 1, 2022 · Completed: Sep 1, 2026
2 conditions1 sponsor1 location
NCT06378762
Interference of Endurance Training on Strength Development and Neuromuscular Adaptations
NAActive, not recruiting
30 participants
Started: Apr 1, 2022 · Completed: Jul 30, 2025
1 condition2 sponsors1 location
NCT05370768
Parenting Mindfully Study II
NAActive, not recruiting
269 participants
Started: Apr 1, 2022 · Completed: May 31, 2027
4 conditions1 sponsor1 location
NCT05288803
Improving Rehabilitation for Veterans After Total Knee Arthroplasty Using Individualized Recovery Trajectories
N/ARecruiting
200 participants
Started: Apr 1, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor2 locations
NCT04875260
Taiwan Center of Outcome and Resource Evaluation
N/ARecruiting
600,000 participants
Started: Apr 1, 2022 · Completed: Dec 31, 2040
1 condition1 sponsor10 locations
NCT06405074
Low Intensity Focused Ultrasound for Tobacco Use Disorder: High Resolution Targeting of the Human Insula
NARecruiting
44 participants
Started: Apr 1, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT04903002
Evaluating the Efficacy of Intranasal Oxytocin on Chronic Pain
PHASE2/PHASE3Recruiting
336 participants
Started: Apr 1, 2022 · Completed: Mar 31, 2026
1 condition3 sponsors3 locations
NCT05296408
Exoskeleton Research: Myoelectric Orthosis for Rehab of Severe Chronic Arm Motor Deficits
NARecruiting
60 participants
Started: Apr 1, 2022 · Completed: Apr 1, 2026
1 condition1 sponsor1 location
NCT05132283
Urologic Lymphadenectomy in AMIGO
NARecruiting
20 participants
Started: Apr 1, 2022 · Completed: Dec 26, 2025
2 conditions1 sponsor1 location
NCT04872478
Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults with Relapsed/Refractory AML, ALL, or MPAL
PHASE1Recruiting
50 participants
Started: Apr 1, 2022 · Completed: Mar 31, 2026
3 conditions1 sponsor3 locations
NCT06553911
Exploring the Application Efficacy of Artificial Intelligence (AI) Diagnostic Tools in Medical Imaging (MI) of Respiratory(R) Infectious (I) Disease (D)
NARecruiting
2,000 participants
Started: Apr 1, 2022 · Completed: Dec 1, 2026
3 conditions1 sponsor1 location
NCT05356234
Ignite Study of the Jewish Family and Children's Service of the Suncoast, Inc.
NARecruiting
675 participants
Started: Apr 1, 2022 · Completed: Jun 1, 2025
2 conditions1 sponsor1 location
NCT05933330
Hereditary Hemorrhagic Telangiectasia and Neurovascular Manifestations, in the Danish HHT Database
N/AActive, not recruiting
300 participants
Started: Apr 1, 2022 · Completed: Jul 31, 2025
2 conditions1 sponsor1 location
NCT05284136
Exclusion Diet vs corticosteroIds in patientS With activE Crohn's Disease
PHASE2/PHASE3Not yet recruiting
80 participants
Started: Apr 1, 2022 · Completed: Apr 1, 2026
1 condition1 sponsor2 locations
NCT05169229
Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement.
PHASE2/PHASE3Recruiting
1,100 participants
Started: Apr 1, 2022 · Completed: Dec 31, 2031
4 conditions3 sponsors1 location
NCT04605913
Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC
PHASE1/PHASE2Recruiting
40 participants
Started: Apr 1, 2022 · Completed: Mar 1, 2026
4 conditions2 sponsors1 location
NCT05332288
Triphasic Osteochondral Scaffold for the Treatment of the OCD of the Knee: Observational Study
N/ARecruiting
30 participants
Started: Apr 1, 2022 · Completed: Apr 30, 2029
1 condition1 sponsor1 location
NCT04919122
Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma
N/AActive, not recruiting
468 participants
Started: Apr 1, 2022 · Completed: Jul 31, 2026
1 condition6 sponsors14 locations
NCT05273879
Necessity of Fusion Following Decompression Surgery in Patients With Single-level Lumbar Stenosis
NAActive, not recruiting
86 participants
Started: Apr 1, 2022 · Completed: Dec 30, 2026
3 conditions4 sponsors3 locations
NCT05284539
Efficacy of Platinum-based Chemotherapy Plus Immune Checkpoint Inhibitors for EGFR/ALK/ROS1 Mutant Lung Cancer
PHASE2Recruiting
760 participants
Started: Apr 1, 2022 · Completed: Oct 10, 2027
1 condition1 sponsor1 location
NCT05335174
Hypotension Prediction Index in Postoperative Surgical Patients
N/ARecruiting
30 participants
Started: Apr 1, 2022 · Completed: Mar 1, 2027
1 condition1 sponsor1 location
NCT05260619
Lenalidomide Maintenance Treatment in Patients With Primary Central Nervous System Lymphoma
PHASE2Recruiting
28 participants
Started: Apr 1, 2022 · Completed: Apr 1, 2028
1 condition2 sponsors1 location
NCT05206435
Methadone-Maintained Smokers Switching to E-Cigarettes
PHASE4Active, not recruiting
240 participants
Started: Mar 31, 2022 · Completed: Jun 30, 2025
2 conditions2 sponsors1 location
NCT05284682
Metabolic Characterization of Patients With Dilated Cardiomyopathy
N/ARecruiting
90 participants
Started: Mar 31, 2022 · Completed: Jan 31, 2026
2 conditions2 sponsors1 location
NCT05024097
A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.
PHASE2Recruiting
43 participants
Started: Mar 31, 2022 · Completed: Dec 31, 2030
1 condition2 sponsors3 locations
NCT05286879
Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations
NAActive, not recruiting
600 participants
Started: Mar 31, 2022 · Completed: Dec 31, 2025
6 conditions2 sponsors3 locations
NCT05178914
Personalized Medicine Using Coronary Microvascular Function Measured in Patient With Percutaneous Coronary Intervention in Angina
NARecruiting
280 participants
Started: Mar 31, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05303714
PIPAC in Multimodal Therapy for Patients with Oligometastatic Peritoneal Gastric Cancer
PHASE3Recruiting
98 participants
Started: Mar 31, 2022 · Completed: Sep 30, 2028
1 condition1 sponsor1 location